|
Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >
Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events
This item is licensed under:Creative Commons Attribution-NonCommercial 4.0 International
| Title: | Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events |
| Authors: | Imafuku, Keisuke Browse this author | | Yoshino, Koji Browse this author | | Yamaguchi, Kei Browse this author | | Tsuboi, Satoshi Browse this author | | Ohara, Kuniaki Browse this author | | Hata, Hiroo Browse this author →KAKEN DB |
| Keywords: | Nivolumab | | Immune-related adverse event | | Re-administration | | Unresectable malignant melanoma | | Cryptogenic organizing pneumonia | | Diffuse alveolar damage | | Pneumonitis |
| Issue Date: | Apr-2017 |
| Publisher: | Karger |
| Journal Title: | Case Reports in Oncology |
| Volume: | 10 |
| Issue: | 1 |
| Start Page: | 296 |
| End Page: | 300 |
| Publisher DOI: | 10.1159/000463379 |
| PMID: | 28512413 |
| Abstract: | Nivolumab is a recently approved medication for the treatment of unresectable malignant melanoma. Many immune-related adverse events (irAEs) associated with nivolumab have been reported, such as pneumonitis, hepatitis, dermatitis, and thyroiditis. Prednisolone can effectively treat irAEs. However, it is unclear how or if nivolumab should be administered to patients after they have experienced an irAE. Herein, we show 2 patients who underwent pneumonitis as irAE. Case 1 demonstrated a cryptogenic organizing pneumonia pattern in the CT scan and case 2 had a diffuse alveolar damage (DAD) pattern. Oral corticosteroids improved chest shadow of CT scan in both cases. However, when nivolumab was re-administrated, case 1 demonstrated no symptoms, but case 2 demonstrated pneumonia again. From our cases, it is difficult to re-administrate nivolumab for the patients with pneumonitis which shows a DAD pattern in CT, even if oral corticosteroids improve their symptoms. |
| Rights: | The final, published version of this article is available at http://www.karger.com/?doi=10.1159/000463379 | | https://creativecommons.org/licenses/by-nc/4.0/ |
| Type: | article |
| URI: | http://hdl.handle.net/2115/67613 |
| Appears in Collections: | 医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 秦 洋郎
|
